Pfizer
Ty Lin has a robust background in the pharmaceutical industry and military leadership. As a Director at Pfizer from June 2018 to April 2021, Ty Lin held key roles in Novel Anti-Infectives Commercial Development and Rare Disease Portfolio & Decision Analysis, as well as serving as a Senior Manager in Portfolio & Decision Analysis. Prior military experience includes serving as an Infantry Officer in the United States Army from May 2009 to July 2014, with responsibilities as a Platoon Leader and Company Executive Officer. Academic qualifications include a Master of Business Administration (M.B.A.) from Harvard Business School, attained between January 2014 and January 2016, and a Bachelor's Degree in Biology/Biological Sciences from the United States Military Academy at West Point, completed in January 2009, with notable involvement in various academic and extracurricular activities.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.